ArticleNanotechnology, science and applications2025
Electrospun Nanofibers for the Delivery of Endolysin/Dendronized Ag-NPs Complex Against Pseudomonas aeruginosa.
Article in Nanotechnology, science and applications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: As bacterial resistance to antibiotics increases, there is an urgent need to identify alternative antibacterial agents and improve antibacterial materials. One is the controlled transport of antibacterial agents that prevents infection with drug-resistant bacteria, especially in the treatment of difficult-to-heal wounds. Methods: This work presents the use of electrospun PLCL/PVP (poly(L-lactide-co-ε-caprolactone/polyvinylpyrrolidone) nanofibers modified with two agents with antibacterial properties but with different mechanisms of action, that is, dendritic silver nanoparticles (Dend-AgNPs) and endolysin. Results: The nanomat prepared in this manner showed significant antibacterial activity against antibiotic-resistant Pseudomonas aeruginosa strains, inhibiting their growth and production of key pigments and virulence factors. Moreover, the use of nanofibers as carriers of the selected factors significantly reduced their cytotoxicity towards human fibroblasts. Conclusion: The results confirmed the possibility of using the presented product as an innovative dressing material, opening new perspectives for the treatment of wounds and combating bacterial infections with drug-resistant bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.